BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 24975396)

  • 1. STAT of the union: dynamics of distinct tumor-associated macrophage subsets governed by STAT1.
    Van Overmeire E; Laoui D; Keirsse J; Bonelli S; Lahmar Q; Van Ginderachter JA
    Eur J Immunol; 2014 Aug; 44(8):2238-42. PubMed ID: 24975396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment.
    Van Overmeire E; Stijlemans B; Heymann F; Keirsse J; Morias Y; Elkrim Y; Brys L; Abels C; Lahmar Q; Ergen C; Vereecke L; Tacke F; De Baetselier P; Van Ginderachter JA; Laoui D
    Cancer Res; 2016 Jan; 76(1):35-42. PubMed ID: 26573801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population.
    Laoui D; Van Overmeire E; Di Conza G; Aldeni C; Keirsse J; Morias Y; Movahedi K; Houbracken I; Schouppe E; Elkrim Y; Karroum O; Jordan B; Carmeliet P; Gysemans C; De Baetselier P; Mazzone M; Van Ginderachter JA
    Cancer Res; 2014 Jan; 74(1):24-30. PubMed ID: 24220244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage dynamics are regulated by local macrophage proliferation and monocyte recruitment in injured pancreas.
    Van Gassen N; Van Overmeire E; Leuckx G; Heremans Y; De Groef S; Cai Y; Elkrim Y; Gysemans C; Stijlemans B; Van de Casteele M; De Baetselier P; De Leu N; Heimberg H; Van Ginderachter JA
    Eur J Immunol; 2015 May; 45(5):1482-93. PubMed ID: 25645754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions.
    Laoui D; Movahedi K; Van Overmeire E; Van den Bossche J; Schouppe E; Mommer C; Nikolaou A; Morias Y; De Baetselier P; Van Ginderachter JA
    Int J Dev Biol; 2011; 55(7-9):861-7. PubMed ID: 22161841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ proliferation contributes to accumulation of tumor-associated macrophages in spontaneous mammary tumors.
    Tymoszuk P; Evens H; Marzola V; Wachowicz K; Wasmer MH; Datta S; Müller-Holzner E; Fiegl H; Böck G; van Rooijen N; Theurl I; Doppler W
    Eur J Immunol; 2014 Aug; 44(8):2247-62. PubMed ID: 24796276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined GM-CSF treatment and M-CSF inhibition of tumor-associated macrophages induces dendritic cell-like signaling in vitro.
    Kitoh Y; Saio M; Gotoh N; Umemura N; Nonaka K; Bai J; Vizkeleti L; Torocsik D; Balazs M; Adany R; Takami T
    Int J Oncol; 2011 May; 38(5):1409-19. PubMed ID: 21373754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPAR gamma is highly expressed in F4/80(hi) adipose tissue macrophages and dampens adipose-tissue inflammation.
    Bassaganya-Riera J; Misyak S; Guri AJ; Hontecillas R
    Cell Immunol; 2009; 258(2):138-46. PubMed ID: 19423085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An mRNA atlas of G protein-coupled receptor expression during primary human monocyte/macrophage differentiation and lipopolysaccharide-mediated activation identifies targetable candidate regulators of inflammation.
    Hohenhaus DM; Schaale K; Le Cao KA; Seow V; Iyer A; Fairlie DP; Sweet MJ
    Immunobiology; 2013 Nov; 218(11):1345-53. PubMed ID: 23948647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Human mammary carcinoma. A model for the relationship between tumor proliferation, tumor-associate macrophages, and prognostic factors].
    Müller H
    Veroff Pathol; 1992; 138():1-235. PubMed ID: 1323168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte/macrophage recruitment, activation and differentiation modulate interleukin-8 production: a paracrine role of tumor-associated macrophages in tumor angiogenesis.
    Varney ML; Olsen KJ; Mosley RL; Bucana CD; Talmadge JE; Singh RK
    In Vivo; 2002; 16(6):471-7. PubMed ID: 12494891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-10 acts as a developmental switch guiding monocyte differentiation to macrophages during a murine peritoneal infection.
    Nguyen HH; Tran BT; Muller W; Jack RS
    J Immunol; 2012 Sep; 189(6):3112-20. PubMed ID: 22869902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unsuspected allies: chemotherapy teams up with immunity to fight cancer.
    Laoui D; Van Overmeire E; Van Ginderachter JA
    Eur J Immunol; 2013 Oct; 43(10):2538-42. PubMed ID: 24122755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice.
    Aharinejad S; Paulus P; Sioud M; Hofmann M; Zins K; Schäfer R; Stanley ER; Abraham D
    Cancer Res; 2004 Aug; 64(15):5378-84. PubMed ID: 15289345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transition of tumor-associated macrophages from MHC class II(hi) to MHC class II(low) mediates tumor progression in mice.
    Wang B; Li Q; Qin L; Zhao S; Wang J; Chen X
    BMC Immunol; 2011 Aug; 12():43. PubMed ID: 21813021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
    Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
    Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated macrophages promote invasion while retaining Fc-dependent anti-tumor function.
    Grugan KD; McCabe FL; Kinder M; Greenplate AR; Harman BC; Ekert JE; van Rooijen N; Anderson GM; Nemeth JA; Strohl WR; Jordan RE; Brezski RJ
    J Immunol; 2012 Dec; 189(11):5457-66. PubMed ID: 23105143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF-1-dependent red pulp macrophages regulate CD4 T cell responses.
    Kurotaki D; Kon S; Bae K; Ito K; Matsui Y; Nakayama Y; Kanayama M; Kimura C; Narita Y; Nishimura T; Iwabuchi K; Mack M; van Rooijen N; Sakaguchi S; Uede T; Morimoto J
    J Immunol; 2011 Feb; 186(4):2229-37. PubMed ID: 21239712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage Susceptibility to Emactuzumab (RG7155) Treatment.
    Pradel LP; Ooi CH; Romagnoli S; Cannarile MA; Sade H; Rüttinger D; Ries CH
    Mol Cancer Ther; 2016 Dec; 15(12):3077-3086. PubMed ID: 27582524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 augmented activation of tumor associated macrophage plays the main role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro.
    Ouyang GF; Saio M; Suwa T; Imai H; Nakagawa J; Nonaka K; Umemura N; Kijima M; Takami T
    Int J Oncol; 2006 May; 28(5):1201-8. PubMed ID: 16596236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.